Premium Nahrungsergänzungsmittel | artgerecht

Paraoxonase 1 (PON1): Function & Significance

Paraoxonase 1 (PON1) is a blood enzyme bound to HDL cholesterol that protects against oxidative stress, atherosclerosis, and the toxic effects of organophosphate compounds.

Regular tips about health Regular tips about health

Things worth knowing about "Paraoxonase 1"

Paraoxonase 1 (PON1) is a blood enzyme bound to HDL cholesterol that protects against oxidative stress, atherosclerosis, and the toxic effects of organophosphate compounds.

What is Paraoxonase 1?

Paraoxonase 1 (PON1) is an enzyme primarily produced in the liver and transported in the bloodstream bound to HDL cholesterol (high-density lipoprotein). It belongs to the paraoxonase enzyme family (PON1, PON2, PON3) and plays a central role in protecting the body against oxidative stress and in detoxifying certain chemical compounds.

Mechanism of Action

PON1 acts as an antioxidant enzyme, protecting both LDL and HDL cholesterol from oxidation. Oxidized LDL is considered a primary driver of atherosclerosis (hardening of the arteries). By inhibiting LDL oxidation, PON1 helps slow the formation of plaques within blood vessels.

In addition, PON1 exhibits the following enzymatic activities:

Lactonase activity: Hydrolysis of lactones and thiolactones, including certain lipid peroxides.
Arylesterase activity: Hydrolysis of aromatic esters.
Phosphotriesterase activity: Breakdown of organophosphates such as the pesticide paraoxon, from which the enzyme takes its name.

Medical Significance

Cardiovascular Disease

Low PON1 activity is associated with an increased risk of heart attack, stroke, and coronary artery disease. Since PON1 inhibits lipoprotein oxidation, it is considered a key component of the cardioprotective function of HDL cholesterol. A high HDL level alone is therefore not always sufficient -- the activity of the bound PON1 plays an additional role.

Diabetes Mellitus

In people with type 2 diabetes, PON1 activity is often reduced, which may contribute to increased oxidative stress and elevated cardiovascular risk.

Detoxification of Organophosphates

PON1 plays an important role in the detoxification of organophosphate pesticides and certain nerve agents (e.g., sarin). Individual differences in PON1 activity, influenced by genetic variants (polymorphisms), can significantly affect susceptibility to such substances.

Other Conditions

Altered PON1 activity has also been associated with the following conditions:

Chronic kidney disease
Rheumatoid arthritis and other autoimmune disorders
Metabolic syndrome
Neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's disease)

Genetic Variants (Polymorphisms)

PON1 activity in the blood varies widely between individuals and is strongly influenced by genetic polymorphisms in the PON1 gene. The variants Q192R and L55M are particularly well studied and affect both enzyme activity and plasma levels of PON1. These differences may explain why some individuals are more susceptible to organophosphates or have a higher cardiovascular risk.

Factors Influencing PON1 Activity

Various lifestyle and environmental factors can influence PON1 activity:

Diet: A Mediterranean diet rich in olive oil, polyphenols, and antioxidants can increase PON1 activity.
Exercise: Regular physical activity is associated with increased PON1 activity.
Smoking: Tobacco use can reduce PON1 activity.
Alcohol: Moderate consumption may increase activity, while excessive consumption may reduce it.
Medications: Statins (cholesterol-lowering drugs) can increase PON1 activity.
Organophosphate exposure: Chronic exposure to pesticides can inhibit PON1 activity.

Diagnostics and Measurement

PON1 activity can be measured in blood serum or plasma using various substrates to assess its different enzymatic activities (paraoxonase, arylesterase, and lactonase activity). This measurement is currently primarily a research parameter and is not yet routinely used in clinical diagnostics, but is gaining increasing clinical relevance.

References

Mackness, M. & Mackness, B. (2015): Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene, 567(1), 12–21. https://doi.org/10.1016/j.gene.2015.04.088
Aviram, M. & Rosenblat, M. (2004): Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Current Opinion in Lipidology, 15(4), 417–423.
Camps, J. et al. (2011): Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in gram-negative bacteria. Chemotherapy, 57(4), 353–364.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category